Sameer M. Zuberi

Active 1999–2025

89
Papers
24,879
Citations
66
h-index
86
i10-index

Citations

Citations per year for Sameer M. Zuberi1987: 1 citations1998: 2 citations2000: 7 citations2001: 16 citations2002: 30 citations2003: 24 citations2004: 29 citations2005: 17 citations2006: 24 citations2007: 32 citations2008: 49 citations2009: 35 citations2010: 42 citations2011: 47 citations2012: 52 citations2013: 74 citations2014: 62 citations2015: 89 citations2016: 83 citations2017: 121 citations2018: 150 citations2019: 816 citations2020: 984 citations2021: 965 citations2022: 973 citations2023: 735 citations2024: 1,374 citations2025: 584 citations2026: 15 citations1988–1997: no citations, so these years are not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,855 citing papers, 18.2% of this breakdownUnited Kingdom: 874 citing papers, 8.6% of this breakdownItaly: 715 citing papers, 7% of this breakdownChina: 653 citing papers, 6.4% of this breakdownGermany: 611 citing papers, 6% of this breakdownAustralia: 548 citing papers, 5.4% of this breakdownFrance: 445 citing papers, 4.4% of this breakdownCanada: 405 citing papers, 4% of this breakdownNetherlands: 337 citing papers, 3.3% of this breakdownSpain: 250 citing papers, 2.5% of this breakdownBelgium: 230 citing papers, 2.3% of this breakdownIndia: 215 citing papers, 2.1% of this breakdown
0%18.2%Other 29.8%

Fields

  • Medicine58.7%
  • Biochemistry, Genetics and Molecular Biology21%
  • Neuroscience14.4%
  • Immunology and Microbiology3.3%
  • Computer Science0.4%
  • Environmental Science0.3%
  • Other1.9%

Topics

  • Epilepsy research and treatment18.1%
  • Neuroscience and Neuropharmacology Research7%
  • Pharmacological Effects and Toxicity Studies5.2%
  • Genetics and Neurodevelopmental Disorders3.7%
  • Genomics and Rare Diseases3.6%
  • EEG and Brain-Computer Interfaces3.5%
  • Other58.9%

Coauthors

All papers

Open in search
  1. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

    Authors: , , , , , , , , , , , , , , , - Epilepsia 2017 cited by 4,881

  2. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology

    Authors: , , , , , , , , , , , - Epilepsia 2017 cited by 3,392

  3. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions

    Authors: , , , , , , , , , , , , , , , , , , , - Epilepsia 2022 cited by 832

  4. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions

    Authors: , , , , , , , , , , , , , , , , , , - Epilepsia 2022 cited by 887

  5. Instruction manual for the ILAE 2017 operational classification of seizure types

    Authors: , , , , , , , , , , , , , , , , , - Epilepsia 2017 cited by 980

  6. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions

    Authors: , , , , , , , , , , , , , , , , , , , , , - Epilepsia 2022 cited by 442

  7. Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

    Authors: , , , , , , , , , , - New England Journal of Medicine 2018 cited by 977

  8. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Vincent, Margaret T. Wilson - Brain 2019 cited by 454

  9. Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE Task Force on Nosology and Definitions

    Authors: , , , , , , , , , , , , , , , , , , , , , - Epilepsia 2022 cited by 273

  10. Global synergistic actions to improve brain health for human development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexandra Heumber Perry, Ericka L. Fink, Peer Baneke, Anne Helme, Joanna Laurson-Doube, Marco T. Medina, Juan David Roa, Birgit Högl, Allan O’Bryan, Claudia Trenkwalder, Jo M. Wilmshurst, Rufus Akinyemi, Joseph Yaria, David C. Good, Volker Hoemberg, Paul Boon, Samuel Wiebe, J. Helen Cross, Magali Haas, Inez Jabalpurwala, Marijeta Mojasevic, Mónica Di Luca, Paola Barbarino, Stéphanie Clarke, Sameer M. Zuberi, Paul Olowoyo, Ayomide Owolabi, Nelson M. Oyesiku, Pia C. Sundgren, Bo Norrving, Surjo R. Soekadar, Pieter A. van Doorn, Richard Lewis, Tom Solomon, Franco Servadei - Nature Reviews Neurology 2023 cited by 113

  11. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iain B. McInnes, Manoj P. Menezes, Cyril Mignot, James O’Sullivan, Simona Orcesi, Paolo Picco, Enrica Riva, Robert A. Robinson, Diana Rodriguez, E. Salvatici, Christiaan Scott, Marta Szybowska, John Tolmie, Adeline Vanderver, Catherine Vanhulle, José Pedro Vieira, Kate Webb, Robyn Whitney, Simon G. Williams, Lynne A. Wolfe, Sameer M. Zuberi, Sun Hur, Yanick J. Crow - Nature Genetics 2014 cited by 591

  12. Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Brain 2021 cited by 244

  13. Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Epilepsia Open 2020 cited by 276

  14. Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens

    Authors: , , , , , , , , , , , , , , , , , - JAMA Neurology 2019 cited by 241

  15. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

    Authors: , , , , , , , , , , , , , , , - Journal of the Japan Epilepsy Society 2019 cited by 511

  16. International League Against Epilepsy classification and definition of epilepsy syndromes with onset at a variable age: position statement by the ILAE Task Force on Nosology and Definitions

    Authors: , , , , , , , , , , , , , , , , , , , - Epilepsia 2022 cited by 260

  17. Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome

    Authors: , , , , , , , , , , , , , , , , , - JAMA Neurology 2022 cited by 124

  18. Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

    Authors: , , , , , , , , , , , , , , , , , , - Neurology 2018 cited by 451

  19. The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures

    Authors: , , , , , , , , , , , , , - Epilepsia 2021 cited by 336

  20. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sameer M. Zuberi, Dennis Lal, Rikke S. Møller, Massimo Mantegazza, Sandrine Cestèle - Brain 2022 cited by 156

  21. A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants

    Authors: , , , , , , , , , - Brain 2020 cited by 159

  22. The burden of illness in Lennox–Gastaut syndrome: a systematic literature review

    Authors: , , , , - Orphanet Journal of Rare Diseases 2023 cited by 62

  23. Gene variant effects across sodium channelopathies predict function and guide precision therapy

    Authors: , , , , , , , , , , - Brain 2022 cited by 106

  24. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome

    Authors: , , , , - Brain 2012 cited by 359